Abstract
No AccessJournal of UrologyAdult Urology1 Jul 2010Urological Oncology: Prostate Cancer Patrick C. WalshM.D. Patrick C. WalshPatrick C. Walsh More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.03.153AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Effect of Dutasteride on the Risk of Prostate Cancer 1 : Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer. Prostate2005; 63: 231. Google Scholar 2 : The influence of finasteride on the development of prostate cancer. N Engl J Med2003; 349: 215. Google Scholar 3 : The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia: Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med1998; 338: 557. Google Scholar 4 : Re: The Prostate Cancer Prevention Trial: design, biases and interpretation of study results. J Urol2006; 176: 2744. Link, Google Scholar 5 : Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial. Br J Cancer2009; 101: 843. Google Scholar Prostate Cancer and PSA Among Statin Users in the Finnish Prostate Cancer Screening Trial 1 : Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial. Br J Cancer2009; 101: 843. Google Scholar © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 184Issue 1July 2010Page: 174-177 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Patrick C. Walsh More articles by this author Expand All Advertisement PDF downloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.